750 reports of this reaction
3.3% of all NIACIN reports
#1 most reported adverse reaction
FATIGUE is the #1 most commonly reported adverse reaction for NIACIN, manufactured by Avondale Pharmaceuticals, LLC. There are 750 FDA adverse event reports linking NIACIN to FATIGUE. This represents approximately 3.3% of all 22,654 adverse event reports for this drug.
Patients taking NIACIN who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among NIACIN users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for NIACIN:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 750 FDA reports for NIACIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.3% of all adverse event reports for NIACIN, making it one of the most commonly reported side effect.
If you experience fatigue while taking NIACIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.